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The last ten years have witnessed increasing awareness of questionable research practices 
(QRPs) in the life sciences [1,2], including p-hacking [3], HARKing [4], lack of replication [5], 
publication bias [6], low statistical power [7] and lack of data sharing ([8]; see Figure 1). Concerns 
about such behaviours have been raised repeatedly for over half a century [9–11] but the incentive 
structure of academia has not changed to address them.  
Despite the complex motivations that drive academia, many QRPs stem from the simple fact 
that the incentives which offer success to individual scientists conflict with what is best for  
science [12]. On the one hand are a set of gold standards that centuries of the scientific method have 
proven to be crucial for discovery: rigour, reproducibility, and transparency. On the other hand are a 
set of opposing principles born out of the academic career model: the drive to produce novel and 
striking results, the importance of confirming prior expectations, and the need to protect research 
interests from competitors. Within a culture that pressures scientists to produce rather than discover, 
the outcome is a biased and impoverished science in which most published results are either 
unconfirmed genuine discoveries or unchallenged fallacies [13]. This observation implies no moral 
judgement of scientists, who are as much victims of this system as they are perpetrators. 
While there is no single answer to QRPs, we believe that a key part of the solution is to reform 
academic publishing. For too long the life sciences have been dominated by an incentive structure in 
which success depends on presenting results that are impressive, novel, clear, and groundbreaking. 
Many journals warn authors that falling short of these benchmarks will lead to manuscripts being 
rejected, often before peer review even takes place. Such policies are born from the hubristic 
ambition—and commercial imperative—of each journal to be regarded as the outlet of choice for the 
most important discoveries in its particular field, with the highest-impact journals setting the 
standard for such policies. 
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Figure 1. The hypothetico-deductive model of the scientific method is compromised 
by a range of questionable research practices (QRPs; red). Lack of replication 
impedes the elimination of false discoveries and weakens the evidence base 
underpinning theory. Low statistical power increases the chances of missing true 
discoveries and reduces the likelihood that obtained positive effects are real. 
Exploiting researcher degrees of freedom (p-hacking) manifests in two general 
forms: collecting data until analyses return statistically significant effects, and 
selectively reporting analyses that reveal desirable outcomes. HARKing, or 
hypothesizing after results are known, involves generating a hypothesis from the 
data and then presenting it as a priori. Publication bias occurs when journals reject 
manuscripts on the basis that they report negative or undesirable findings. Finally, 
lack of data sharing prevents detailed meta-analysis and hinders the detection of 
data fabrication. 
These incentives do great harm to both science and scientists. By selecting which papers to 
publish based on the results of experiments, we motivate scientists to engage in dishonesty and 
delusion, burying negative findings in the file drawer and spinning cherry picked data into 
“publishable” packages. 
Reforming this system will require us to apply the rigour of the scientific method to the editorial 
process itself. Fortunately we already have a precedent for such a mechanism. In clinical drug trials it 
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is standard practice for researchers to be initially blinded as to whether individual patients are 
receiving the treatment or the placebo—this prevents the desires of the researchers from biasing the 
study outcome. We believe this logic should also apply to scientific publishing: in reaching editorial 
decisions, journal editors should remain blind to the results in order to minimize the effect of their 
own bias on the scientific record.  
Registered Reports 
The most secure way to prevent publication bias, p-hacking, and HARKing is for authors to 
pre-register their hypotheses and planned analyses before the collection of data. In return, if the 
rationale and methods are sound then the journal should agree to publish the final paper regardless of 
the specific outcome. This format of publishing has become known as the Registered Reports (RR) 
model and was first introduced in 2013 by the journal Cortex [14] together with a related format at 
Perspectives on Psychological Science.1
The RR model integrates pre-registration into scientific publishing through a two-stage peer 
review process, summarised in Figure 2. Authors initially submit a Stage 1 manuscript that includes 
an Introduction, Methods, and the results of any pilot experiments that motivate the research 
proposal. 
 Since then, RRs have been taken up and launched by 
several other journals, including Attention, Perception & Psychophysics [15], Experimental 
Psychology [16], Drug and Alcohol Dependence [17], Social Psychology [18], and now AIMS 
Neuroscience.  
Following assessment of the protocol by editors and reviewers, the manuscript can then be 
offered in principle acceptance (IPA), which means that the journal virtually guarantees publication if 
the authors conduct the experiment in accordance with their approved protocol. With IPA in hand, the 
researchers can then implement the experiment. Following data collection, they resubmit a Stage 2 
manuscript that includes the Introduction and Methods from the original submission plus the Results 
and Discussion. The Results section includes the outcome of the pre-registered analyses together 
with any additional unregistered analyses in a separate section titled “Exploratory Analyses”. 
Authors must also share their data on a public and freely accessible archive such as Figshare and are 
encouraged to release data analysis scripts. The final article is published only after this process is 
complete. A published Registered Report will thus appear very similar to a standard research report 
but will give readers confidence that the hypotheses and main analyses are free of QRPs. Detailed 
author and reviewer guidelines to RRs are available on the AIMS Neuroscience website at 
http://www.aimspress.com/reviewers.pdf. 
The RR model at AIMS Neuroscience will also incorporate the Badges initiative maintained by 
the Center for Open Science, which recognises adherence to transparent research practices. All RRs 
will automatically qualify for the Preregistration and Open Data badges. Authors who additionally 
share data analysis scripts will be awarded an Open Materials badge. The badges will be printed in 
the title bar of published articles. For more information on badges, authors are referred to 
https://osf.io/tvyxz/wiki/home/ or invited to contact the AIMS Neuroscience editorial board at 
Neuroscience@aimspress.com.  
 
 
                                                             1 https://www.psychologicalscience.org/index.php/replication 
7 
 
AIMS Neuroscience  Volume 1, Issue 1, 4-17. 
 
 
Figure 2. The submission pipeline and review criteria for Registered Reports at 
AIMS Neuroscience. Further details can be found at 
http://www.aimspress.com/reviewers.pdf. 
Responses to questions and concerns about Registered Reports 
In June 2013, a group of more than 80 scientists signed an open letter to the Guardian 
newspaper in the United Kingdom calling for RRs to be introduced across the life sciences [19]. The 
signatories to this letter included researchers and members of journal editorial boards spanning 
epidemiology, genetics, clinical and experimental medicine, neuroscience, physiology, pharmacology, 
psychiatry, and psychology. In response, a number of neuroscientists voiced concerns about the RR 
model and possible unintended consequences of this new format [20,21]. We respond below to 25 of 
their most pressing concerns and related FAQs. 
1. Can’t authors cheat the Registered Reports model by ‘pre-registering’ a protocol for a study 
they have already completed? 
Under the current RR model this is not possible without committing fraud. When authors 
submit a Stage 2 manuscript it must be accompanied by a basic laboratory log indicating the range of 
dates during which data collection took place together with a certification from all authors that no 
data was collected prior to the date of IPA (other than pilot data included in the Stage 1 submission). 
Time-stamped raw data files generated by the pre-registered study must also be shared publicly, with 
the time-stamps post-dating IPA. Submitting a Stage 1 protocol for a completed study would 
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therefore constitute an act of deliberate misconduct.  
Beyond these measures, fraudulent pre-registration would backfire for authors because editors 
are likely to require revisions to the proposed experimental procedures following Stage 1 review. 
Even minor changes to the protocol would of course be impossible if the experiment had already 
been conducted, and would therefore defeat the purpose of pre-registration. Unless authors were 
willing to engage in further dishonesty about what their experimental procedures involved, 
“pre-registering” a completed study would be a highly ineffective publication strategy.  
It bears mention that no publishing mechanism, least of all the status quo, can protect science 
against complex and premeditated acts of fraud. By requiring certification and data sharing, the RR 
model closes an obvious loophole that opportunistic researchers might exploit where doing so didn’t 
require the commission of outright fraud. But what RRs achieve, above all, is to incentivise 
adherence to the scientific method by eliminating the pressure to massage data, reinvent hypotheses, 
or behave dishonestly in the first place. 
2. Won’t Registered Reports become a dumping ground for negative or ambiguous findings 
that have little impact? 
For studies that employ null hypothesis significance testing (NHST), adequate statistical power 
is crucial for interpreting all findings, whether positive or negative. Low power not only increases 
the chances of missing genuine effects; it also reduces the likelihood that statistically significant 
effects are genuine [7]. To address both concerns, RRs that include NHST-based analyses must 
include a priori power of ≥  90% for all tests of the proposed hypotheses. Ensuring high statistical 
power increases the credibility of all findings, regardless of whether they are clearly positive, clearly 
negative or inconclusive.  
It is of course the case that statistical non-significance, regardless of power, can never be taken 
as direct support for the null hypothesis. However this reflects a fundamental limitation of NHST 
rather than a shortcoming of the RR model. Authors wishing to estimate the likelihood of any given 
hypothesis being true, whether H0 or H1, are welcome to adopt alternative Bayesian inferential 
methods as part of their RR submissions [22–24]. 
3. Won’t Registered Reports limit data exploration and the reporting of unexpected results? 
This is one of the most commonly voiced concerns about RRs and would be a legitimate worry 
if the RR model limited the reporting of study outcomes to pre-registered analyses only. However, 
we stress that no such constraint applies at AIMS Neuroscience or for RRs launched at any other 
journal. To be clear, the RR model places no restrictions on the reporting of unregistered exploratory 
analyses — it simply requires that the Results section of the final article distinguishes those analyses 
that were pre-registered and confirmatory from those that were post hoc and exploratory. Ensuring a 
clear separation between confirmatory hypothesis testing and exploratory analysis is vital for 
preserving the evidential value of both forms of enquiry [11].  
In contrast to what several critics have suggested [20,21], RRs will not hinder the reporting of 
unexpected or serendipitous findings. On the contrary the RR model will protect such observations 
from publication bias. Editorial decisions for RRs are made independently of whether the results 
support the pre-registered hypotheses; therefore Stage 2 manuscripts cannot be rejected because 
editors or reviewers find the outcomes of hypothesis testing to be surprising, counterintuitive, or 
unappealing. This stands in contrast to conventional peer review, where editorial decisions are 
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routinely based on the extent to which results conform to prior expectations or desires. 
4. How are Registered Reports different from clinical trial registration? 
Some scientists have criticised the RR model on the grounds that is apparently reinventing the 
existing pre-registration mechanism used in medical research and attempting to apply it to basic 
science. This argument overlooks the three key features that advance RRs beyond clinical trial 
registration. First, RRs enjoy continuity of the review process from the initial Stage 1 submission to 
the final publication, thus ensuring that authors remain true to their registered protocol. This is 
particularly salient given that only 1 in 3 peer reviewers of clinical research compare authors’ 
protocols to their final submitted manuscripts [25]. Second, in contrast to RRs, most forms of clinical 
trial registration (e.g. clinicaltrials.gov) do not peer review study protocols, which provides the 
opportunity for authors to (even unconsciously) include sufficient “wiggle room” in the methods or 
proposed analyses to allow later p-hacking or HARKing [2,4,26]. Third, even in the limited cases 
where journals do review and publish trial protocols (e.g. Lancet Protocol Reviews, BMC Protocols, 
Trials), none of these formats provides any guarantee that the journal will publish the final outcome. 
These features of the RR model ensure that it represents a substantial innovation over and above 
existing systems of study pre-registration. 
5. Why are Registered Reports needed for grant-funded research? Isn’t the process of grant 
assessment in itself a form of pre-registration? 
There are many differences between these types of review. The level of detail in the assessment 
of RRs differs at a scalar level from grants — a funding application typically includes only a general 
or approximate description of the methods to be employed, whereas a Stage 1 RR includes a 
step-by-step account of the experimental procedures and analysis plan. Furthermore, since 
researchers frequently deviate from their funded protocols, which themselves are rarely published, 
the suitability of successful funding applications as registered protocols is extremely limited. Finally, 
RRs are intended to provide an option that is suitable for all applicable research, not only studies that 
are supported by grant funding. 
6. Where authors are unable to predict the likely effect size for an experiment, how can they 
report a power analysis as part of a Stage 1 submission? 
Statistical power analysis requires prior estimation of expected effect sizes. Because our 
research culture emphasizes the need for novelty of both methods and results, it is understandable 
that researchers may sometimes feel there is no appropriate precedent for their particular choice of 
methodology. In such cases, however, a plausible effect size can usually be gleaned from related 
prior work. After all, very few experimental designs are truly unique and exist in isolation. Even 
when the expected effect size is inestimable, the RR model welcomes the inclusion of pilot results in 
Stage 1 submissions to establish probable effect sizes for subsequent pre-registered experimentation. 
Where expected effect sizes cannot be estimated and authors have no pilot data, a minimal 
effect size of theoretical interest can be still used to determine a priori power. Authors can also adopt 
NHST approaches with corrected peeking (e.g. [27]) or Bayesian methods that specify a prior 
distribution of possible effect sizes rather than a single point estimate [24]. Interestingly, in informal 
discussions, some researchers — particularly in neuroimaging — have responded to concerns about 
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power on the grounds that they do not care about the size of an effect, only whether or not an effect 
is present. The problem with this argument is that if the effect under scrutiny has no lower bound of 
theoretical importance then the experimental hypothesis (H1) becomes unfalsifiable, regardless of 
power. 
7. Setting a requirement of 90% for statistical power is unrealistic for expensive methods and 
would require impossibly large sample sizes. The Registered Reports format therefore 
disadvantages researchers who work with expensive techniques or who have limited resources. 
It is true that RRs are not suitable for underpowered experiments. But underpowered 
experiments themselves are detrimental to science, dragging entire fields down blind alleys and 
limiting the potential for reproducibility [28]. We would argue that if a particular research field 
systematically fails to reach the standards of statistical power set by RRs then this is not “unfair” but 
rather a deep problem within that field that needs to be addressed. One solution is to combine 
resources across research teams to increase power, such as the highly successful IMAGEN fMRI 
consortium [29]. 
8. If reviewers have only the proposed design and methods to assess, won’t they rely more on 
the reputation of the authors in judging study protocols? This could make life harder for 
scientists who are more junior or less influential. 
Structured review criteria mean that reviewers must find concrete reasons for arguing that a 
Stage 1 submission is inappropriate or flawed. Author reputation is not among them. To provide 
further assurance, the RR format at AIMS Neuroscience will employ masked review in which the 
reviewers are blinded as much as possible to the identity of the authors.  
9. Sometimes a design is sound, but the data are uninterpretable because researchers run the 
experiment poorly. How will Registered Reports distinguish negative findings and unexpected 
results arising from poor practice from those that are genuine? 
As noted in the Stage 1 publication criteria, authors must include outcome-neutral conditions for 
ensuring that the proposed methods are capable of testing the stated hypotheses. These might include 
positive control conditions, manipulation checks, and standard benchmarks such as the absence of 
floor and ceiling effects. Manuscripts that fail to specify these criteria will not be offered IPA, and 
Stage 2 submissions that fail any critical outcome-neutral tests will not be accepted for publication. 
10. If publication is guaranteed in advance, why would researchers bother running their 
experiments carefully? This scheme could incentivize false negatives arising from sloppy 
research practices. 
For this criticism to be valid, scientists would need to be motivated solely by the act of 
publishing, with no desire to make true discoveries or to build a coherent body of research findings 
across multiple publications. We are more optimistic about the motivations of the scientific 
community, but nevertheless, it is important to note that running a pre-registered study carelessly 
would also sabotage the outcome-neutral tests (see #9) that are necessary for final acceptance of the 
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Stage 2 submission.  
11. Stage 1 submissions must have institutional ethical approval to be considered for IPA, and 
such ethical approval can be highly specific. This means that if a researcher has to change 
anything about their study design to obtain IPA, the ethics application would need to be 
amended and resubmitted to the ethics committee. This back-and-forth will be too 
time-consuming and bureaucratic for many researchers. 
This is a legitimate concern with no easy solution. An ideal strategy, where possible, is to build 
in minor procedural flexibility when applying for ethics approval. The RR editorial team at AIMS 
Neuroscience is happy to provide letters of support for authors seeking to amend ethics approval 
following Stage 1 peer review. 
12. How will RRs prevent pre-registrations for studies that have no funding or approvals and 
will never actually happen? 
Some scientists have argued out that the RR model could increase the workload for reviewers if 
authors were to deliberately submit more protocols than they could carry out. As one critic put it: 
“Pre-registration sets up a strong incentive to submit as many ideas/experiments as possible to as 
many high impact factor journals as possible” [20]. Armed with IPA, the researcher could then 
prepare grant applications to support only the successful protocols, discarding the rejected ones. 
Were such a strategy to be widely adopted it could indeed overburden the peer review system.  
Again, however, this problem does not apply to the RR model at AIMS Neuroscience or at any 
of the other journals where the format has been launched. All Stage 1 submissions must include a 
cover letter stating that all necessary support (e.g. funding, facilities) and approvals (e.g. ethics) are 
already in place and that the researchers could start immediately following IPA. Since these 
guarantees could not be made for unsupported proposals, this concern is moot. 
13. Pre-registration of hypotheses and analysis plans is too arduous to be feasible for authors. 
The amount of work required to prepare an RR is similar to conventional manuscript 
preparation; the key difference is that much of the work is done before, rather than after, data 
collection. The fact that researchers often decide their hypotheses and analysis strategies after an 
experiment is complete [2] doesn’t change the fact that these decisions still need to be made. And the 
reward for thinking through these decisions in advance, rather than at the end, is that IPA virtually 
guarantees a publication. 
14. The peer review process for Registered Reports includes two phases. Won’t this create too 
much additional work for reviewers? 
It is true that peer review under the RR model is more thorough than conventional manuscript 
review. However, critics who raise this point overlook a major shortcoming of the conventional 
review process: the fact that manuscripts are often rejected sequentially by multiple journals, passing 
through many reviewers before finding a home. Under the RR model, at least two of the problems 
that lead to such systematic rejection, and thus additional load on reviewers, are circumvented. First, 
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reviewers of Stage 1 submissions have the opportunity to help authors correct methodological flaws 
before they occur by assessing the experimental design prior to data collection. Second, because RRs 
cannot be rejected based on the perceived importance of the results, the RR model avoids a common 
reason for conventional rejection: that the results are not considered sufficiently novel or 
groundbreaking. 
We believe the overall reviewer workload under the RR model will be similar to conventional 
publishing. Consider a case where a conventional manuscript is submitted sequentially to four 
journals, and the first three journals reject it following 3 reviews each. The fourth journal accepts the 
manuscript after 3 reviews and 3 re-reviews. In total the manuscript will have been seen by up to 12 
reviewers and gone through 15 rounds of review. Now consider what might have happened if the 
study had been submitted prior to data collection as a Stage 1 RR, assessed by 3 reviewers. Even if it 
passes through three rounds of Stage 1 review plus two rounds of Stage 2 review, the overall 
reviewer burden (15 rounds) is the same as the conventional model (15 rounds).  
15. Reviewers could steal my ideas at the pre-registration stage and scoop me. 
This is an understandable concern but highly unlikely. Only a small group of individuals will 
know about Stage 1 submissions, including the editors plus a small set of reviewers; and the 
information in Stage 1 submissions is not published until the study is completed. It is also 
noteworthy that once IPA is awarded, the journal cannot reject the final Stage 2 submission because 
similar work was published elsewhere in the meantime. Therefore, even in the unlikely event of a 
reviewer rushing to complete a pre-registered design ahead of the authors, such a strategy would 
confer little career advantage for the perpetrator (especially because the ‘manuscript received’ date in 
the final published RR refers to the initial Stage 1 submission date and so will predate the 
‘manuscript received’ date of any standard submission published by a competitor). Concerns about 
being scooped do not stop researchers applying for grant funding or presenting ideas at conferences, 
both of which involve releasing ideas to a larger group of potential competitors than would typically 
see a Stage 1 RR. 
16. What is to stop authors with IPA withdrawing their manuscript after getting striking 
results and resubmitting it to a higher impact journal? 
Nothing. Contrary to some stated concerns [20], authors are free to withdraw their manuscript at 
any time and are not “locked” into publishing with the journal that reviews the Stage 1 submission. If 
the withdrawal happens after IPA has been awarded, the journal will simply publish a Withdrawn 
Registration that includes the abstract from the Stage 1 submission plus a brief explanation for the 
withdrawal.  
17. Some of my analyses will depend on the results, so how can I pre-register each step in 
detail?  
Pre-registration does not require every step of an analysis to be specified or “hardwired”; 
instead, in such cases where the analysis decision is contingent on some aspect of the data itself then 
the pre-registration only requires the decision tree to be specified (e.g. “If A is observed then we will 
adopt analysis A1 but if B is observed then we will adopt analysis B1”). Authors can thus pre-register 
the contingencies and rules that underpin future analysis decisions.  
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It bears reiterating that not all analyses need to be pre-registered — authors are welcome to 
report the outcome of exploratory tests for which specific steps or contingencies could not be 
determined in advance of data collection. 
18. I have access to an existing data set that I have not yet analysed. Can I submit this proposed 
analysis as a Registered Report? 
No. The current RR model applies only to original research. However we agree that a 
pre-registered article type for existing data sets would be a useful additional form of RRs. 
19. My aim is to publish a series of experiments but the design of the later experiments is 
contingent upon the outcomes of the earlier ones. Isn’t Registered Reports limited to single 
experiments? 
No. The RR model welcomes sequential registrations in which authors add experiments at Stage 
1 via an iterative mechanism and complete them at Stage 2. With each completed cycle, the previous 
accepted version of the paper is guaranteed to be published, regardless of the outcome of the next 
round of experimentation. Authors are also welcome to submit a Stage 1 manuscript that includes 
multiple parallel experiments. 
20. How will RRs incentivise replications? 
Replications are can be expensive and carry little career benefit to authors. Ensuring that a 
direct replication is convincing often requires a much larger sample than the original study. Once 
completed, a replication can be difficult to publish because many journals refuse to report them, 
regardless of the outcome. Unless there is an assurance of publication in advance, it can make little 
sense from a strategic point of view for life scientists to pursue direct replications. IPA provides this 
assurance and thus offers the strongest possible incentive for scientists to directly replicate previous 
work. 
21. Registered Reports is based on a naïve conceptualisation of the scientific method.  
We believe this criticism is misplaced. Some scientists may well believe that the 
hypothetico-deductive model is the wrong way to frame science, but if so, why do they routinely 
publish articles that test hypotheses and report p values? Those who oppose the 
hypothetico-deductive model are not raising a specific argument against RRs — they are criticising 
the fundamental way research is taught and published in the life sciences. We are agnostic about such 
concerns and simply note that the RR model aligns the way science is taught with the way it is 
published. 
22. As a junior researcher, I need to publish in high-impact journals. Until Nature / Science / 
PNAS offer Registered Reports, why would I settle for publishing in a specialist journal? 
This is a legitimate concern that will not be settled until life scientists either dispel the myth that 
journal hierarchy reflects quality [30] or the most prestigious journals offer RRs. The RR model is 
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spreading quickly to many journals, and we believe it is only a matter of time before high-impact 
outlets come on board. In the meantime there are several rewards for junior scientists who choose the 
RR model where it is available. First, because RRs are immune to publication bias they ensure that 
high quality science is published regardless of the outcome. This means that a PhD student could 
publish every high-quality study from their PhD rather than selectively publishing the studies that 
“worked”. Second, a PhD student who submits RRs has the opportunity to gain IPA for several 
papers before even submitting their PhD, which in the stiff competition for post-doctoral jobs may 
provide an edge over graduates with fewer deliverables to show. Third, because RRs neutralise 
various QRPs, such as p-hacking, HARKing and low statistical power, it is likely that the findings 
they contain will be more reproducible, on average, than those in comparable unregistered articles.  
23. Much of my research stems from student projects, which operate over too short a time scale 
to be suitable for Registered Reports. 
This is a legitimate concern that cannot be solved by the RR model. However, one way authors 
can address this is to design and pre-register student projects several months before students 
commence. Although the cover letter for RRs requires certification that the study could commence 
immediately, it is possible to negotiate a delayed commencement date with the editors. 
24. Registered Reports may not apply to my specific field therefore it is not a good solution. 
Contrary to what some critics have suggested [21], the RR model has never been proposed as a 
“panacea” for all fields of science or all sub-disciplines within fields. On the contrary we have 
emphasised that “pre-registration doesn't fit all forms of science, and it isn't a cure-all for scientific 
publishing” [19]. Furthermore, to suggest that RRs are invalid because they don't solve all problems 
is to fall prey to the perfect solution fallacy in which a useful partial solution is discarded in favour 
of a non-existent complete solution. 
Some scientists have further prompted us to explain which types of research the RR model 
applies to and which it does not [20]. Ultimately such decisions are for the scientific community to 
reach as a whole, but we believe that the RR model is appropriate for any area of hypothesis-driven 
science that suffers from publication bias, p-hacking, HARKing, low statistical power, or a lack of 
direct replication. If none of these problems exist or the approach taken isn’t hypothesis-driven then 
the RR model need not apply because nothing is gained by pre-registration. 
25. Registered Reports may become seen as the gold standard for scientific publishing, which 
would unfairly disadvantage exploratory or observational studies that cannot be 
pre-registered. 
This need not be the case. It bears reiterating that the RR model does not prevent or hinder 
exploration — it simply enables readers to distinguish confirmatory hypothesis testing from 
exploratory analysis. Under the conventional publishing system, scientists are pressured to engage in 
QRPs in order to present exploration as confirmation (e.g. HARKing). Some researchers may even 
apply NHST in situations where it is not appropriate because there is no a priori hypothesis to be 
tested. Distinguishing confirmation from exploration can only disadvantage scientists who rely on 
exploratory approaches but, at the same time, feel entitled to present them as confirmatory.  
We believe this concern reflects a deeper problem that the life sciences do not adequately value 
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exploratory, non-hypothesis driven research. Rather than threatening to devalue exploratory research, 
the RR model is the first step toward liberating it from this hegemony and increasing its traction. 
Once the boundaries between confirmation and exploration are made clear we can be free to develop 
a format of publication that is dedicated solely to reporting exploratory and observational studies. We 
know of at least one journal that, having launched RRs, is now poised to trial a complementary 
“Exploratory Reports” format. Rather than criticizing the RR model for devaluing exploration, our 
community would do better to push reforms that highlight the benefits of purely exploratory 
research. 
Conclusions 
The unique selling point of Registered Reports is its prevention of publication bias and QRPs in 
hypothesis testing. This article has introduced the format at AIMS Neuroscience and outlined our 
response to a number of the most pressing concerns. As we note in the beginning, our purpose is not 
to preach or to admonish — it is to inspire researchers to consider an alternative pathway and to 
provide a clear incentive for engaging in transparent practices. Pre-registration carries the reward of 
assuring readers that a scientist’s practices adhered to the hypothetico-deductive method, which 
benefits individual practitioners as much as it benefits science. As Leif Nelson has put it: 
Note that this line of thinking is not even vaguely self-righteous. It isn’t pushy. I am not 
saying, “you have to preregister or else!” Heck, I am not even saying that you should; I am 
saying that I should. In a world of transparent reporting, I choose preregistration as a way 
to selfishly show off that I predicted the outcome of my study. [31] 
Over the coming years we look forward to seeing Registered Reports expand across more 
journals and scientific fields, challenging traditional hegemonies and altering incentive structures. In 
parallel with this initiative, pre-registration of basic science is growing in prominence at the Open 
Science Framework (https://osf.io/), and the 2013 revision of the Declaration of Helsinki (DoH) now 
requires some form of study pre-registration for all research involving humans [32]. Although this 
requirement technically applies only to clinical research, many of the major journals that publish 
basic neuroscience also request or require adherence to the DoH, such as the Journal of 
Neuroscience 2 and Cerebral Cortex 3
The feedback we have received from the academic community has been invaluable in helping 
us shape this initiative. In return we hope this editorial responds usefully to some of the most 
frequent questions and concerns. 
. The Registered Reports model complements these advances 
by incentivising rigour and reproducibility. 
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